Page 11 - Processa Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Item 2. Management's Discussion and Analysis of Financial Condition and Results of... | May 15, 2023

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) shares traded down 2.8% during trading on Monday . The stock traded as low as $0.62 and last traded at $0.70. 177,993 shares traded hands during mid-day trading, a decline of 22% from the average session volume of 227,829 shares. The stock had previously closed at $0.72. Analyst […]

Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) shares gained ground Friday, as the company, a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients ...

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) was the recipient of a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 186,400 shares, a drop of 41.7% from the March 15th total of 319,700 shares. Based on an average daily volume of 274,600 shares, the […]

Processa Pharmaceuticals (NASDAQ:PCSA – Get Rating) had its price target decreased by Benchmark from $9.00 to $4.00 in a research report released on Tuesday morning, Benzinga reports. Benchmark currently has a speculative buy rating on the stock. A number of other analysts have also recently issued reports on PCSA. Oppenheimer cut their price objective on […]